First Mercantile Trust’s NovoCure NVCR Stock Holding History

First Mercantile Trust’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$68K	Sell	584 -62	-10%	-$9.37K	0.01%	738
2021 Q2	$143K	Buy	+646	New	+$126K	0.02%	565
2020 Q2	–	Sell	-1,383	Closed	-$93K	–	927
2020 Q1	$93K	Sell	1,383 -61	-4%	-$4.82K	0.01%	577
2019 Q4	$122K	Buy	1,444 +336	+30%	+$27.1K	0.01%	619
2019 Q3	$83K	Buy	+1,108	New	+$88.6K	0.01%	743

Other funds holding NVCR

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Mercantile Trust's NVCR Position: Q3 2021 in Review

First Mercantile Trust reduced its NovoCure (NVCR) stake by 9.6% in Q3 2021, selling an estimated $9.37K and leaving 584 shares worth $68K. The position accounts for 0.01% of the portfolio, ranked #738.

First Mercantile Trust first reported a position in NVCR in Q3 2019 and has held it in 5 quarters since. The position peaked at $143K in Q2 2021. 317 funds tracked by Wall St. Rank hold NVCR as of Q3 2021.

First Mercantile Trust held 584 shares of NovoCure worth $68K as of Q3 2021.
First Mercantile Trust sold 62 NovoCure shares in Q3 2021, an estimated $9.37K.
NovoCure made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #738 holding.
First Mercantile Trust first reported a position in NovoCure in Q3 2019 and has held it in 5 quarters since.
First Mercantile Trust's NovoCure position peaked at $143K in Q2 2021.
317 funds tracked by Wall St. Rank held NovoCure as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.